Decreased IL-10+ regulatory B cells (Bregs) in lupus nephritis patients

Scandinavian Journal of Rheumatology

Volumn 45, Issue 4, 2016, Pages 312-316

  Heinemann, K ^a   Wilde, B ^a   Hoerning, A ^b   Tebbe, B ^a   Kribben, A ^a   Witzke, O ^a   Dolff, S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD19 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; INTERLEUKIN 10; IONOMYCIN; MYCOPHENOLIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISOLONE; CALCIUM IONOPHORE; CD19 MOLECULE, HUMAN; CD24 PROTEIN, HUMAN; CD38 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; MEMBRANE PROTEIN; OLIGODEOXYRIBONUCLEOTIDE; PHORBOLOL MYRISTATE ACETATE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE COUNT; MIDDLE AGED; YOUNG ADULT;

ADULT; ANTIGENS, CD19; ANTIGENS, CD24; ANTIGENS, CD38; B-LYMPHOCYTES, REGULATORY; CALCIUM IONOPHORES; CASE-CONTROL STUDIES; FEMALE; HUMANS; IN VITRO TECHNIQUES; INTERLEUKIN-10; IONOMYCIN; LUPUS NEPHRITIS; LYMPHOCYTE COUNT; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; TETRADECANOYLPHORBOL ACETATE; YOUNG ADULT;

EID: 84975225210     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2015.1126346     Document Type: Article

References (15)

1. S.Dolff, W.H.Abdulahad, M.Bijl, C.G.Kallenberg Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion? Lupus 2009;18:575–80.
2. S.Dolff, B.Wilde, S.Patschan, J.Durig, C.Specker, T.Philipp, et al. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Scand J Immunol 2007;66:584–90.
3. P.E.Lipsky. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001;2:764–6.
4. N.Lepse, W.H.Abdulahad, A.Rutgers, C.G.Kallenberg, C.A.Stegeman, P.Heeringa. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. Rheumatology (Oxford) 2014;53:1683–92.
5. K.S.van der Geest, W.H.Abdulahad, P.Chalan, A.Rutgers, G.Horst, M.G.Huitema, et al. Disturbed B cell homeostasis in patients with newly-diagnosed giant cell arteritis and polymyalgia rheumatica. Arthritis Rheumatol 2014;66:1927–38.
6. B.Wilde, M.Thewissen, J.Damoiseaux, S.Knippenberg, M.Hilhorst, P.van Paassen, et al. Regulatory B cells in ANCA-associated vasculitis. Ann Rheum Dis 2013;72:1416–19.
7. I.Kalampokis, A.Yoshizaki, T.F.Tedder. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 2013;15:S1.
8. P.A.Blair, L.Y.Norena, F.Flores-Borja, D.J.Rawlings, D.A.Isenberg, M.R.Ehrenstein, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010;32:129–40.
9. J.D.Bouaziz, S.Calbo, M.Maho-Vaillant, A.Saussine, M.Bagot, A.Bensussan, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010;40:2686–91.
10. R.Watanabe, N.Ishiura, H.Nakashima, Y.Kuwano, H.Okochi, K.Tamaki, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010;184:4801–9.
11. A.Saussine, A.Tazi, S.Feuillet, M.Rybojad, C.Juillard, A.Bergeron, et al. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. Plos One 2012;7:e43588.
12. X.Yang, J.Yang, Y.Chu, Y.Xue, D.Xuan, S.Zheng, et al. T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus. Plos One 2014;9:e88441.
13. S.Fillatreau, C.H.Sweenie, M.J.McGeachy, D.Gray, S.M.Anderton. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002;3:944–50.
14. J.Sieber, C.Daridon, S.J.Fleischer, V.Fleischer, F.Hiepe, T.Alexander, et al. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation. Arthritis Res Ther 2014;16:477.
15. L.Wang, P.Zhao, L.Ma, Y.Shan, J.Wang, Y.Jiang, et al. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus. J Rheumatol 2014;41:1781–92.